Pavmed Inc.-CW24PAVMZPreferred / convertible

13F holders, Q4 2024 (December 31)
4holders +1
1new positions
0sold out
1famous investor
$0.01avg. 13F price*

At the end of Q4 2024, 4 institutions reported holding Pavmed Inc.-CW24 (PAVMZ) in their 13F filings, up 1 from Q3 2024. 1 opened new positions and 0 sold out. The largest holders were Susquehanna International Group, LLP ($1K), Citadel Advisors ($425) and UBS Group AG ($77). One famous investor held it Ken Griffin ( of Citadel Advisors's portfolio).

Company
Pavmed Inc.-CW24
CUSIP
70387R122
Latest filing quarter
Q1 2025

History

Number of 13F holders

01234 Q1 2024: 2Q1 2024Q2 2024: 3Q2 2024Q3 2024: 3Q3 2024Q4 2024: 4Q4 2024Q1 2025: 4Q1 2025

Total Exit/New Position Q3 2024 → Q4 2024

InstitutionsTotal Value
New Positions1$1K
Exits0$0

All 13F filers, Q3 2024 → Q4 2024: 138,395 shares bought and 749 shares sold, net +137,646 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 4 holders

Susquehanna International Group, LLP — New 138,195 $1K
Citadel Advisors — Add +0.5% 42,892 $425
UBS Group AG — Reduce -8.9% 7,708 $77
Bank of America Corp. — No change 100 $1

"% of holder's portfolio" is PAVMZ's weight in each manager's 13F, not the share of Pavmed Inc.-CW24 the manager owns.